title: Correlation between case mix index and antibiotic use in hospitals.
abstract: BACKGROUND
  To compare the quantitative antibiotic use between hospitals or hospital units and to explore differences, adjustment for severity of illness of hospitalized patients is essential. The case mix index (CMI) is an economic surrogate marker (i.e. the total cost weights of all inpatients per a defined time period divided by the number of admissions) to describe the average patients' morbidity of individual hospitals. We aimed to investigate the correlation between CMI and hospital antibiotic use.
  
  
  METHODS
  We used weighted linear regression analysis to evaluate the correlation between in-hospital antibiotic use in 2006 and CMI of 18 departments of the tertiary care University Hospital Zurich and of 10 primary and 2 secondary acute care hospitals in the Canton of Zurich in Switzerland.
  
  
  RESULTS
  Antibiotic use varied substantially between different departments of the university hospital [defined daily doses (DDD)/100 bed-days, 68.04; range, 20.97-323.37] and between primary and secondary care hospitals (range of DDD/100 bed-days, 15.45-57.05). Antibiotic use of university hospital departments and the different hospitals, respectively, correlated with CMI when calculated in DDD/100 bed-days [coefficient of determination (R(2)), 0.57 (P = 0.0002) and 0.46 (P = 0.0065)], as well as when calculated in DDD/100 admissions [R(2), 0.48 (P = 0.0008) and 0.85 (P < 0.0001), respectively].
  
  
  CONCLUSIONS
  Antibiotic use correlated with CMI across various specialties of a university hospital and across different acute care hospitals. For benchmarking antibiotic use within and across hospitals, adjustment for CMI may be a useful tool in order to take into account the differences in hospital category and patients' morbidities.
authors.affiliation: Division of Infectious Diseases and Hospital Epidemiology, University Hospital, Zurich, Switzerland.
authors.forename: Stefan P
authors.initials: SP
authors.lastname: Kuster
authors.forename: Christian
authors.initials: C
authors.lastname: Ruef
authors.forename: Alfred K
authors.initials: AK
authors.lastname: Bollinger
authors.forename: Bruno
authors.initials: B
authors.lastname: Ledergerber
authors.forename: Andreas
authors.initials: A
authors.lastname: Hintermann
authors.forename: Clau
authors.initials: C
authors.lastname: Deplazes
authors.forename: Lutz
authors.initials: L
authors.lastname: Neuber
authors.forename: Rainer
authors.initials: R
authors.lastname: Weber
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004363:Drug Utilization / Q000706:statistics & numerical data*; D006761:Hospitals; D016014:Linear Models; D020379:Risk Adjustment; D013223:Statistics as Topic; D013557:Switzerland
chemical_list: D000900:Anti-Bacterial Agents